|
BMI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.104760E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.149900E-02 |
| Normal-vs-Stage2 |
3.595600E-01 |
| Normal-vs-Stage3 |
6.568800E-01 |
| Normal-vs-Stage4 |
5.372400E-01 |
| Stage1-vs-Stage2 |
4.342800E-01 |
| Stage1-vs-Stage3 |
7.914500E-02 |
| Stage1-vs-Stage4 |
1.467690E-02 |
| Stage2-vs-Stage3 |
6.271200E-01 |
| Stage2-vs-Stage4 |
1.795850E-01 |
| Stage3-vs-Stage4 |
3.476600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.696020E-01 |
| Normal-vs-AfricanAmerican |
3.328400E-01 |
| Normal-vs-Asian |
4.264100E-02 |
| Caucasian-vs-AfricanAmerican |
6.929000E-01 |
| Caucasian-vs-Asian |
2.225800E-01 |
| AfricanAmerican-vs-Asian |
6.696800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.389000E-01 |
| Normal-vs-Female |
6.489900E-02 |
| Male-vs-Female |
2.202600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.699500E-02 |
| Normal-vs-Age(41-60Yrs) |
8.917800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.438400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.202200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.374800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.970150E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.527600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.526200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.404400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.691000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.424550E-01 |
| Classical-VS-Follicular |
3.201800E-02 |
| Classical-VS-Other |
5.970000E-01 |
| Classical-VS-Normal |
1.640430E-02 |
| Tall-VS-Follicular |
9.832800E-01 |
| Tall-VS-Other |
8.180600E-01 |
| Tall-VS-Normal |
8.865400E-01 |
| Follicular-VS-Other |
8.575400E-01 |
| Follicular-VS-Normal |
8.542200E-01 |
| Other-VS-Normal |
7.309400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.480800E-01 |
| Normal-vs-N1 |
7.737800E-01 |
| N0-vs-N1 |
4.314600E-01 |
|
|
